Clinical Trial Modernization Act
This bill aims to increase participation in clinical trials among underrepresented populations - including racial/ethnic minorities, rural residents, and other historically excluded groups - by addressing financial and logistical barriers. It creates federal grants to fund community outreach, training for diverse clinical trial staff, and partnerships with community organizations. The bill also allows sponsors to cover participants' out-of-pocket costs (like travel and meals) and provide necessary digital tools without violating fraud laws, while making such payments tax-free up to $2,000 per year. These changes directly affect drug/device manufacturers, clinical trial sites, and underserved communities seeking equitable access to medical research.
Bill status
in committee
1 of 4 stages cleared
Introduction
May 2024
Committee Review
Floor Vote
President
Introduced May 15, 2024
Last action Dec 17, 2024
Floor votes
How they voted
No floor votes recorded yet.
Full legislative history
Actions timeline
Total actions
4
Key actions
0
Committee
3
Dec 17, 2024
Committee
Referred to the Subcommittee on Health.
lower
May 17, 2024
Committee
Referred to the Subcommittee on Health.
lower
May 15, 2024
Committee
Referred to the Committee on Energy and Commerce, and in addition to the Committee on Ways and Means, for a period to be subsequently determined by the Speaker, in each case for consideration of such provisions as fall within the jurisdiction of the committee concerned.
lower
May 15, 2024
Introduced
Introduced in House
lower
1 primary · 5 co-sponsors
Sponsors
Ask Maddy
·
AI policy assistant
Ask Maddy about HR 8412
Scope: US
Hi! I can help you understand HR 8412. What would you like to know?
Try one of these
i
Maddy answers using official bill text and legislative records. Always verify before sharing.
Sources cited inline